Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

ASP-1929 for the Treatment of Head and Neck Squamous Cell Carcinomas

ASP-1929 is a conjugate of cetuximab and IRDye 700DX®. Image courtesy of Rakuten Aspyrian.

  • ASP-1929
  • ASP-1929
  • ASP-1929

Go Top